CRL-2938: Lymphoma

Charles River Laboratories


Related Models
PDX model Engraftment
Host Strain Name Site Type Material Material Status Passage
NOD SCID GAMMA NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
Not Specified Not Specified Not Specified Not Specified 3, 4
NSG NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
Not Specified Not Specified Not Specified Not Specified 3
NSG NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ 
subcutaneous/intraveneously orthotopic cell suspension Not Specified 0, 3
Model Quality Control
Technique Description Passage
flow cytometry high concordance between xenograft and patient <5
Patient
Sex male
Ethnicity caucasian
Derived Model CRL-2938
Patient Tumor Collection For PDX Model
Collection (Current Model)
Age 57
Diagnosis Lymphoma
Type recurrent
PDX Mouse CRL-2938
Collection Site not provided
Grade ( Classification: )
Stage not provided ( Classification: not provided)
Date Regimen Started Regimen Dose Best Response Duration (Months)
Cyclophosphamide and Doxorubicin and Prednisolone and Rituximab and Vincristine NA / NA / NA / NA / NA Not Specified NA / NA / NA / NA / NA
Sample ID Sample Type Engrafted Tumor Passage Data Type Data Available Platform Used Raw Data
CRL-2378 Engrafted Tumor Passage 4 mutation View data Illumina WES Not Available
CRL-R0160 Engrafted Tumor Passage 3 mutation View data ILLUMINA Not Available
CRL-2378 Engrafted Tumor Passage 3 mutation View data Illumina WES Not Available
CRL-2378 Engrafted Tumor Passage 3 mutation View data RNA sequencing Not Available
CRL-2378 Engrafted Tumor Passage 3 expression View data ILLUMINA Not Available
CRL-2378 Engrafted Tumor Passage 3 expression View data Affymetrix HGU133plus2 Not Available
CRL-R0160 Engrafted Tumor Passage 3 mutation View data Illumina WES Not Available
CRL-R0160 Engrafted Tumor Passage 3 mutation View data RNA sequencing Not Available
CRL-R0160 Engrafted Tumor Passage 3 expression View data ILLUMINA Not Available
CRL-R0160 Engrafted Tumor Passage 3 expression View data Affymetrix HGU133plus2 Not Available

Sample ID:     Histology:     Tumor Type: Engrafted Tumor     Passage:     Platform: